Patient Preference Study

• Status: Completed
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: All

Summary

In this randomized crossover study, patients will receive a single drop of two test articles and assess comfort.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Dorzolamide; Ophthalmic Solutions; Pharmaceutical Solutions; Timolol

Criteria

Inclusion Criteria:

• Sign informed consent;

• Diagnosis of glaucoma or ocular hypertension;

• On a stable regimen of any intraocular pressure (IOP) lowering medication (mono-therapy);

• IOP for which, in the opinion of the investigator, participation in the study does not present a risk to ocular health;

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Best corrected visual acuity worse than 0.60 logMAR (20/80 Snellen) in either eye;

• Pregnant, nursing, or not using highly effective birth control methods;

• Use of oral or topical corticosteroids within 30 days of the Screening Visit and during the course of the study;

• History of bronchial asthma or severe chronic obstructive pulmonary disease;

• Other protocol-defined exclusion criteria may apply.